InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Lockshin Curtis, 董事. Director active across 1 company, notably Phio Pharmaceuticals Corp.. Aggregated, 5 filings have been logged. Activity tracked since 15 February 2022. The latest transaction was filed on 5 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Lockshin Curtis is Administrateur at Phio Pharmaceuticals Corp. The file shows 5 filings in total, all in the recent sample, from 2022-02-16 to 2026-02-06, with the modal transaction nature listed as Attribution and buy and sell amounts of EUR 0.